Literature DB >> 21087935

Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma.

U Löbel1, J Sedlacik, W E Reddick, M Kocak, Q Ji, A Broniscer, C M Hillenbrand, Z Patay.   

Abstract

BACKGROUND AND
PURPOSE: Focal anaplasia characterized by T2 hypointensity, signal-intensity enhancement on postcontrast T1-weighted MR imaging and restricted water diffusion has been reported in a patient with juvenile pilocytic astrocytoma. We identified T2(HOF) with these MR imaging characteristics in children with DIPG and hypothesized that these represent areas of focal anaplasia; and may, therefore, have increased perfusion properties and should be characterized by increased perfusion. Thus, we used DSC to investigate our hypothesis.
MATERIALS AND METHODS: We retrospectively reviewed the baseline MR imaging scans of 86 patients (49 girls, 37 boys; median age, 6.1 years; range, 1.1-17.6 years) treated for DIPG at our hospital (2004-2009). T2(HOF) with the described MR imaging characteristics was identified in 10 patients. We used a region of interest-based approach to compare the ADC, FA, rCBV, rCBF, and rMTT of T2(HOF) with those of the typical T2(HRT).
RESULTS: The ADC of T2(HOF) with the specified MR imaging characteristics was significantly lower than that of T2(HRT) (range, 0.71-1.95 μm(2)/ms versus 1.36-2.13 μm(2)/ms; P < .01); and the FA (range, 0.12-0.34 versus 0.07-0.24; P = .03) and rCBV (range, 0.4-2.62 versus 0.23-1.57; P = .01) values of T2(HOF)s were significantly higher.
CONCLUSIONS: Our data suggest that T2(HOF) in DIPG may represent areas of focal anaplasia and underline the importance of regional, rather than global, tumor-field analysis. T2(HOF) may be the ideal target when stereotactic biopsy of tumors that present with an inhomogeneous T2 signal intensity is considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087935      PMCID: PMC3579511          DOI: 10.3174/ajnr.A2277

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  Diffusion tensor imaging: the normal evolution of ADC, RA, FA, and eigenvalues studied in multiple anatomical regions of the brain.

Authors:  Ulrike Löbel; Jan Sedlacik; Daniel Güllmar; Werner A Kaiser; Jürgen R Reichenbach; Hans-Joachim Mentzel
Journal:  Neuroradiology       Date:  2009-01-09       Impact factor: 2.804

2.  Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.

Authors:  Takashi Inoue; Kuniaki Ogasawara; Takaaki Beppu; Akira Ogawa; Hiroyuki Kabasawa
Journal:  Clin Neurol Neurosurg       Date:  2005-04       Impact factor: 1.876

3.  Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.

Authors:  Andreas Stadlbauer; Stephan Gruber; Christopher Nimsky; Rudolf Fahlbusch; Thilo Hammen; Rolf Buslei; Bernd Tomandl; Ewald Moser; Oliver Ganslandt
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

4.  Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study.

Authors:  C Chaskis; T Stadnik; A Michotte; K Van Rompaey; J D'Haens
Journal:  Acta Neurochir (Wien)       Date:  2006-01-19       Impact factor: 2.216

5.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

6.  Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.

Authors:  Riyadh N Al-Okaili; Jaroslaw Krejza; John H Woo; Ronald L Wolf; Donald M O'Rourke; Kevin D Judy; Harish Poptani; Elias R Melhem
Journal:  Radiology       Date:  2007-05       Impact factor: 11.105

7.  Brain stem gliomas of children. A clinicopathological study.

Authors:  A L Albright; R A Price; A N Guthkelch
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

8.  Clinicopathological study of diffuse type brainstem gliomas: analysis of 40 autopsy cases.

Authors:  Junichi Yoshimura; Kiyoshi Onda; Ryuichi Tanaka; Hitoshi Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-08       Impact factor: 1.742

9.  Brainstem glioma: clinical manifestations of meningeal gliomatosis.

Authors:  R J Packer; J Allen; S Nielsen; C Petito; M Deck; B Jereb
Journal:  Ann Neurol       Date:  1983-08       Impact factor: 10.422

Review 10.  Brainstem glioma with multiple intraspinal metastases during life: case report and review of the literature.

Authors:  D Silbergeld; M Berger; B Griffin; A Bleyer; R Geyer; J Milstein; J Eskridge
Journal:  Pediatr Neurosci       Date:  1988
View more
  35 in total

1.  Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.

Authors:  Tina Young Poussaint; Sridhar Vajapeyam; Kelsey I Ricci; Ashok Panigrahy; Mehmet Kocak; Larry E Kun; James M Boyett; Ian F Pollack; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2015-10-20       Impact factor: 12.300

2.  Arterial spin labeling of hemangioblastoma: differentiation from metastatic brain tumors based on quantitative blood flow measurement.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Kazufumi Kikuchi; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2011-11-10       Impact factor: 2.804

3.  MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.

Authors:  K Yamashita; A Hiwatashi; O Togao; K Kikuchi; R Hatae; K Yoshimoto; M Mizoguchi; S O Suzuki; T Yoshiura; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

Review 4.  Pediatric brainstem gliomas: new understanding leads to potential new treatments for two very different tumors.

Authors:  Adam L Green; Mark W Kieran
Journal:  Curr Oncol Rep       Date:  2015-03       Impact factor: 5.075

5.  Gray Matter Growth Is Accompanied by Increasing Blood Flow and Decreasing Apparent Diffusion Coefficient during Childhood.

Authors:  N D Forkert; M D Li; R M Lober; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-21       Impact factor: 3.825

6.  Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.

Authors:  Robert M Lober; Yoon-Jae Cho; Yujie Tang; Patrick D Barnes; Michael S Edwards; Hannes Vogel; Paul G Fisher; Michelle Monje; Kristen W Yeom
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

Review 7.  MR imaging of brain pilocytic astrocytoma: beyond the stereotype of benign astrocytoma.

Authors:  Simona Gaudino; Matia Martucci; Rosellina Russo; Emiliano Visconti; Emma Gangemi; Francesco D'Argento; Tommaso Verdolotti; Libero Lauriola; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2016-10-18       Impact factor: 1.475

8.  MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma.

Authors:  O Clerk-Lamalice; W E Reddick; X Li; Y Li; A Edwards; J O Glass; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

9.  Correlation between arterial spin-labeling perfusion and histopathological vascular density of pediatric intracranial tumors.

Authors:  Kazufumi Kikuchi; Akio Hiwatashi; Osamu Togao; Koji Yamashita; Koji Yoshimoto; Masahiro Mizoguchi; Satoshi O Suzuki; Toru Iwaki; Yuriko Suzuki; Hiroshi Honda
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

10.  The effects of propofol on cerebral perfusion MRI in children.

Authors:  Julie H Harreld; Kathleen J Helton; Roland N Kaddoum; Wilburn E Reddick; Yimei Li; John O Glass; Rakhee Sansgiri; Qing Ji; Tianshu Feng; Mary Edna Parish; Amar Gajjar; Zoltan Patay
Journal:  Neuroradiology       Date:  2013-05-15       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.